Raymond James Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $11.3M | Sell |
125,481
-11,728
| -9% | -$987K | 0.25% | 91 |
|
|
2024
Q2 | $10.8M | Buy |
137,209
+2,736
| +2% | +$224K | 0.25% | 86 |
|
|
2024
Q1 | $11.7M | Buy |
134,473
+9,212
| +7% | +$786K | 0.28% | 82 |
|
|
2023
Q4 | $10.3M | Sell |
125,261
-2,191
| -2% | -$167K | 0.27% | 82 |
|
|
2023
Q3 | $9.99M | Buy |
127,452
+9,947
| +8% | +$833K | 0.3% | 76 |
|
|
2023
Q2 | $10.4M | Buy |
117,505
+10,469
| +10% | +$901K | 0.3% | 78 |
|
|
2023
Q1 | $8.63M | Buy |
107,036
+18,684
| +21% | +$1.52M | 0.27% | 84 |
|
|
2022
Q4 | $6.87M | Buy |
88,352
+12,210
| +16% | +$990K | 0.23% | 103 |
|
|
2022
Q3 | $6.15M | Buy |
76,142
+3,336
| +5% | +$300K | 0.23% | 101 |
|
|
2022
Q2 | $6.53M | Sell |
72,806
-2,152
| -3% | -$218K | 0.23% | 98 |
|
|
2022
Q1 | $8.32M | Buy |
74,958
+1,982
| +3% | +$209K | 0.26% | 92 |
|
|
2021
Q4 | $7.55M | Buy |
72,976
+3,302
| +5% | +$382K | 0.22% | 105 |
|
|
2021
Q3 | $8.73M | Buy |
69,674
+538
| +0.8% | +$69.6K | 0.29% | 80 |
|
|
2021
Q2 | $8.58M | Buy |
69,136
+409
| +0.6% | +$51.4K | 0.29% | 83 |
|
|
2021
Q1 | $8.12M | Buy |
68,727
+4,860
| +8% | +$570K | 0.28% | 83 |
|
|
2020
Q4 | $7.48M | Buy |
63,867
+1,527
| +2% | +$168K | 0.29% | 83 |
|
|
2020
Q3 | $6.48M | Buy |
62,340
+5,592
| +10% | +$562K | 0.28% | 81 |
|
|
2020
Q2 | $5.2M | Buy |
56,748
+6,368
| +13% | +$611K | 0.25% | 86 |
|
|
2020
Q1 | $4.54M | Buy |
50,380
+2,037
| +4% | +$217K | 0.27% | 87 |
|
|
2019
Q4 | $5.49M | Sell |
48,343
-134
| -0.3% | -$14.7K | 0.26% | 89 |
|
|
2019
Q3 | $5.26M | Buy |
48,477
+4,877
| +11% | +$509K | 0.27% | 86 |
|
|
2019
Q2 | $4.25M | Buy |
43,600
+7,834
| +22% | +$715K | 0.23% | 97 |
|
|
2019
Q1 | $3.26M | Buy |
35,766
+986
| +3% | +$88.2K | 0.19% | 119 |
|
|
2018
Q4 | $3.16M | Sell |
34,780
-1,035
| -3% | -$96.7K | 0.2% | 112 |
|
|
2018
Q3 | $3.52M | Buy |
35,815
+3,184
| +10% | +$294K | 0.2% | 111 |
|
|
2018
Q2 | $2.79M | Buy |
32,631
+4,007
| +14% | +$335K | 0.17% | 130 |
|
|
2018
Q1 | $2.3M | Sell |
28,624
-131
| -0.5% | -$10.8K | 0.16% | 148 |
|
|
2017
Q4 | $2.32M | Sell |
28,755
-1,260
| -4% | -$101K | 0.16% | 145 |
|
|
2017
Q3 | $2.33M | Sell |
30,015
-2,358
| -7% | -$196K | 0.17% | 131 |
|
|
2017
Q2 | $2.87M | Buy |
32,373
+1,850
| +6% | +$156K | 0.21% | 113 |
|
|
2017
Q1 | $2.46M | Buy |
30,523
+1,407
| +5% | +$110K | 0.19% | 120 |
|
|
2016
Q4 | $2.07M | Buy |
29,116
+4,467
| +18% | +$351K | 0.17% | 137 |
|
|
2016
Q3 | $2.13M | Buy |
24,649
+1,450
| +6% | +$126K | 0.18% | 124 |
|
|
2016
Q2 | $2.01M | Sell |
23,199
-1,703
| -7% | -$138K | 0.18% | 127 |
|
|
2016
Q1 | $1.87M | Sell |
24,902
-7,578
| -23% | -$571K | 0.17% | 130 |
|
|
2015
Q4 | $2.5M | Buy |
32,480
+4,962
| +18% | +$374K | 0.23% | 100 |
|
|
2015
Q3 | $1.84M | Sell |
27,518
-833
| -3% | -$61.4K | 0.21% | 109 |
|
|
2015
Q2 | $2.1M | Sell |
28,351
-24,575
| -46% | -$1.88M | 0.22% | 106 |
|
|
2015
Q1 | $4.13M | Buy |
52,926
+35,754
| +208% | +$2.71M | 0.44% | 56 |
|
|
2014
Q4 | $1.24M | Buy |
17,172
+2,721
| +19% | +$189K | 0.13% | 168 |
|
|
2014
Q3 | $896K | Sell |
14,451
-1,922
| -12% | -$122K | 0.1% | 205 |
|
|
2014
Q2 | $1.04M | Sell |
16,373
-847
| -5% | -$51.5K | 0.12% | 179 |
|
|
2014
Q1 | $1.06M | Buy |
17,220
+723
| +4% | +$42.1K | 0.13% | 165 |
|
|
2013
Q4 | $946K | Sell |
16,497
-3,269
| -17% | -$185K | 0.12% | 170 |
|
|
2013
Q3 | $1.05M | Buy |
19,766
+351
| +2% | +$18.9K | 0.16% | 141 |
|
|
2013
Q2 | $999K | Buy |
+19,415
| New | +$960K | 0.16% | 141 |
|
Other funds holding MDT
Raymond James Trust's MDT Position: Q3 2024 in Review
Raymond James Trust reduced its Medtronic (MDT) stake by 8.5% in Q3 2024, selling an estimated $987K and leaving 125,481 shares worth $11.3M. The position accounts for 0.25% of the portfolio, ranked #91.
Raymond James Trust first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $11.7M in Q1 2024. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Raymond James Trust held 125,481 shares of Medtronic worth $11.3M as of Q3 2024.
- Raymond James Trust sold 11,728 Medtronic shares in Q3 2024, an estimated $987K.
- Medtronic made up 0.25% of Raymond James Trust's portfolio in Q3 2024, its #91 holding.
- Raymond James Trust first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
- Raymond James Trust's Medtronic position peaked at $11.7M in Q1 2024.
- 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.